Suchergebnisse - "Jabbour, Elias J"

PubPharm (229)

1

A Review of the Therapeutic Role of Bosutinib in Chronic Myeloid Leukemia

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Kantarjian, H. | Jabbour, E. | Lipton, J. | +2

2

Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation : A single-center phase 1,2 trial

enthalten in: American journal of hematology | 2024

von Khouri, I. | Alzahrani, K. | Kantarjian, H. | +20

3

Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL

enthalten in: bioRxiv.org | 2024

von Zhao, Y. | Short, N. | Kantarjian, H. | +19

4

Sotatercept for anemia of myelofibrosis : a phase II investigator-initiated study

enthalten in: Haematologica | 2024

von Bose, P. | Masarova, L. | Pemmaraju, N. | +21

5

Failure of treatment-free remission after a prolonged deep molecular response in patients with chronic myeloid leukemia

enthalten in: Acta haematologica | 2024

von Nasnas, P. | Jabbour, E. | Sasaki, K. | +4

6

Cytogenetic and Molecular Associations with Outcomes in Higher-Risk Myelodysplastic Syndromes Treated with Hypomethylating Agents plus Venetoclax

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Bazinet, A. | Desikan, S. | Li, Z. | +17

7

Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL

enthalten in: Blood | 2024

von Zhao, Y. | Short, N. | Kantarjian, H. | +19

UpdateOf: medRxiv. 2023 Dec 09;:. - PMID 38106221

8

Inotuzumab in Older Patients with Newly Diagnosed Acute Lymphoblastic Leukemia-A Podcast

enthalten in: Targeted oncology | 2024

von Jabbour, E. | Stelljes, M.

9

Association of leukemic molecular profile with efficacy of inotuzumab ozogamicin in adults with relapsed/refractory ALL

enthalten in: Blood advances | 2024

von Zhao, Y. | Laird, A. | Roberts, K. | +17

10

Recurrent lymphoid and myeloid relapses due to treatment cessations reveal natural history of Ph-positive B-ALL and pose a diagnostic challenge

enthalten in: American journal of hematology | 2024

von Hu, S. | Jabbour, E. | Hu, C. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[23]